Glenn Larsen
Direktor/Vorstandsmitglied bei ANIKA THERAPEUTICS, INC.
Vermögen: 775 662 $ am 30.04.2024
Profil
Glenn R.
Larsen is the founder of Aquinnah Pharmaceuticals, Inc. (founded in 2014) and 180 Therapeutics LP (founded in 2013), where he holds the titles of Chairman, President & Chief Executive Officer and Chairman, respectively.
Currently, he is an Independent Director at Anika Therapeutics, Inc. (since 2015).
Previously, he held Senior Director positions at Genetics Institute LLC (2003-2010) and COO, Director & Executive VP-Development positions at Hydra Biosciences, Inc. (2003-2010).
He was also a Vice President at Wyeth Pharmaceuticals LLC.
From 2010 to 2013, he was the CSO, Executive VP-Research & Development at SpringLeaf Therapeutics, Inc. Dr. Larsen holds a doctorate degree from Stony Brook University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ANIKA THERAPEUTICS, INC.
0,20% | 22.04.2024 | 30 323 ( 0,20% ) | 775 662 $ | 30.04.2024 |
Aktive Positionen von Glenn Larsen
Unternehmen | Position | Beginn |
---|---|---|
ANIKA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 17.02.2015 |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | 01.02.2014 |
180 Therapeutics LP
180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of 180 Life Sciences Corp., 180 Therapeutics LP engages in the development of biological therapies for the treatment of fibrosis. The private company is based in Cambridge, MA. The company was founded by Glenn R. Larsen. | Gründer | 01.01.2013 |
Ehemalige bekannte Positionen von Glenn Larsen
Unternehmen | Position | Ende |
---|---|---|
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.01.2010 |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
Ausbildung von Glenn Larsen
Stony Brook University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ANIKA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
SpringLeaf Therapeutics, Inc.
SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Retail Trade |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
180 Therapeutics LP
180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of 180 Life Sciences Corp., 180 Therapeutics LP engages in the development of biological therapies for the treatment of fibrosis. The private company is based in Cambridge, MA. The company was founded by Glenn R. Larsen. | Health Technology |